This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Ecole Nationale Veterinaire De Maison Alfort, Merial Limited. Active years: 2006.
Company Filing History:
1 out of 1 
1 out of 321 
Years Active: 2006
Title: The Innovations of Bernard Georges Klonjkowski
Introduction
Bernard Georges Klonjkowski is a notable inventor based in Paris, France. He has made significant contributions to the field of viral vectors and vaccines, particularly focusing on recombinant porcine adenoviruses. His work has implications for veterinary medicine and vaccine development.
Latest Patents
Klonjkowski holds a patent for "Viral vectors and viral vaccines based on recombinant porcine adenoviruses." This invention describes an in vivo replicative and recombined porcine adenovirus that includes a heterologous nucleotide sequence. The adenovirus is characterized by its ability to replicate in vivo and express the inserted nucleotide sequence. The patent also details a recombined porcine vaccine that utilizes this innovative adenovirus, which is derived from serotype 3 or 5 porcine adenoviruses.
Career Highlights
Throughout his career, Klonjkowski has worked with prominent organizations such as Merial Limited and Ecole Nationale Veterinaire De Maison Alfort. His experience in these institutions has allowed him to advance his research and contribute to the development of effective veterinary vaccines.
Collaborations
Klonjkowski has collaborated with Marc Eloit, further enhancing his research and innovation in the field of viral vaccines.
Conclusion
Bernard Georges Klonjkowski's work in the development of viral vectors and vaccines showcases his dedication to advancing veterinary medicine. His innovative approaches and collaborations have the potential to significantly impact the field.